Knowledge

United States Preventive Services Task Force

Source 📝

235:. Patients in this age group should be educated about the risks and benefits of screening, and the decision whether to screen or not should be based on the individual situation and preferences. The old advice was based on "weak" evidence for this age group. The new advice is based on improved scientific evidence about the benefits and harms associated with mammography and is consistent with recommendations by the 278:
instructs insurers to disregard the task force's recommendation against frequent routine mammograms in asymptomatic younger women, and requires them to provide free annual mammograms, even for low-risk women, based on the outdated 2002 report. This proposal is not yet law and may change. The efforts
270:
from "B" to "C" (limited evidence prevents a one-size-fits-all recommendation) for routine mammograms in women under the age of 50. With a grade C recommendation, physicians are required to consider additional factors, such as the individual woman's personal risk of breast cancer. Pending health care
310:
The initial USPSTF was created in 1984 as a 5 year appointment to "develop recommendations for primary care clinicians on the appropriate content of periodic health examinations" and was modelled on the Canadian Task Force on Preventive Health Care, established in 1976. This initial 5 year project
31:
and develops recommendations for clinical preventive services". The task force, a volunteer panel of primary care clinicians (including those from internal medicine, pediatrics, family medicine, obstetrics and gynecology, nursing, and psychology) with methodology experience including epidemiology,
639:
Davidson, Karina W.; Barry, Michael J.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Krist, Alex H.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Owens, Douglas K.; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen;
72:
The USPSTF explicitly does not consider cost as a factor in its recommendations, and it does not perform cost-effectiveness analyses. American health insurance groups are required to cover, at no charge to the patient, any service that the USPSTF recommends, regardless of how much it costs or how
220:
The previous advice was for all women over the age of 40 to receive a mammogram every one to two years. The new advice is more detailed. For women between the ages of 50 and 74, they have recommended routine mammograms once every two years in the absence of symptoms. Most American women who are
239:
and other major medical bodies. Their recommendation against routine, suspicion-less mammograms for younger women does not change the advice for screening women at above-average risk for developing breast cancer or for testing women who have a suspicious lump or any other symptoms that might be
81:
The task force assigns the letter grades A, B, C, D, or I to each of its recommendations, and includes "suggestions for practice" for each grade. The Task Force also defined levels of certainty regarding net benefit.
271:
legislation would require insurance companies to cover any and all preventive services that receive an "A" or "B" grade, but permit them to use discretion on preventive services that receive a worse grade.
302:
A final statement published in 2018 recommends basing the decision to screen on shared decision making in those 55 to 69 years old. It continues to recommend against screening in those 70 and older.
217:
in the hope of detecting the disease in an early, easily treatable stage. The advice about using mammography in the presence of symptoms (such as a lump in the breast that can be felt) is unchanged.
224:
The USPSTF declared that there is insufficient evidence to make any statement about the use of mammograms in women over the age of 75, as very little research has been performed in this age group.
127:
Clinicians may provide the service to selected patients depending on individual circumstances. However, for most individuals without signs or symptoms there is likely to be only a small benefit.
1034: 315:. In July 1990, the Department of Health and Human Services reconstituted the Task Force to continue and update these scientific assessments of preventive services. 168:
The evidence is sufficient to determine the effects of the service, but confidence is limited. The conclusion might change as more information becomes available.
138:
The Task Force recommends against this service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits.
482:
Barton MB, Miller T, Wolff T, et al. (2007). "How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force".
877: 415:, Teutsch S, Whitlock E (2007). "Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development". 1024: 468: 295:(PSA)-based screening for prostate cancer screenings be an individual decision for men between the ages of 55 to 69. In 2018 the Task Force gave 565: 1044: 1039: 775: 754: 116:
There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.
1004: 183:
The USPSTF has evaluated many interventions for prevention and found several have an expected net benefit in the general population.
162:: Consistent results from well-designed studies in representative populations that assess the effect of the service on health outcomes. 37: 969: 615: 948: 923: 902: 332: 267: 243:
The change in the recommendation for younger women has been criticized by some physicians and cancer advocacy groups, such as
64:
The methods of evidence synthesis used by the Task Force have been described in detail. In 2007, their methods were revised.
213:. Screening mammograms, or routine mammograms, are X-rays given to apparently healthy women with no symptoms or evidence of 369: 813: 197: 387: 256: 279:
by politicians to reject the committee's scientific findings have been condemned as an example of unwarranted
987: 780: 296: 292: 280: 236: 27:) is "an independent panel of experts in primary care and prevention that systematically reviews the 794: 429: 410: 597: 731: 252: 248: 190:
Colon cancer screening by colonoscopy, occult blood testing, or sigmoidoscopy in adults 45 to 75.
28: 424: 263: 706: 462: 53: 831: 641: 495: 438: 1029: 832:"Role of evidence based medicine in clinical decision-making addressed by ACP in testimony" 691:"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement" 8: 36:, is funded, staffed, and appointed by the U.S. Department of Health and Human Services' 671: 450: 49: 518: 251:, and praised by physicians and medical organizations that support individualized and 981: 749: 710: 675: 663: 573: 546: 538: 499: 442: 454: 702: 653: 530: 491: 434: 33: 853: 149:
The current evidence is insufficient to assess the balance of benefits and harms.
291:
In the current recommendation published in 2018, the Task Force recommended that
1009: 56:, and preventive medications work for adults and children who have no symptoms. 690: 534: 1018: 577: 542: 274:
The Vitter amendment to the Mikulski amendment to pending legislation in the
232: 214: 714: 667: 658: 550: 503: 446: 350: 244: 770: 275: 259:, who currently serves on its Clinical Efficacy Assessment Subcommittee. 228: 412: 193:
Low-dose CT scans for adults 55 to 80 at increased risk of lung cancer
854:"Statement On the Politicization of Evidence-based Clinical Research" 210: 187:
Aspirin in men 45 to 79 and women 55 to 79 for cardiovascular disease
155:
Levels of certainty vary from high to low according to the evidence.
1005:
USPSTF on Agency for Healthcare Research and Quality (AHRQ) website
688: 517:
Pauly, Mark V.; Sloan, Frank A.; Sullivan, Sean D. (2014-11-01).
174:
The evidence is insufficient to assess effects on health outcome.
32:
biostatistics, health services research, decision sciences, and
48:
The USPSTF evaluates scientific evidence to determine whether
566:"Forbidden Topic in Health Policy Debate: Cost Effectiveness" 105:
There is high certainty that the net benefit is substantial.
732:"Screening for Breast Cancer: Recommendations and Rationale" 370:"Factbox: How the U.S. Preventive Services Task Force works" 814:"Task force opposes routine mammograms for women age 40-49" 638: 221:
diagnosed with breast cancer are diagnosed after age 60.
903:"Screening for Prostate Cancer Recommendation Statement" 311:
concluded in 1989 with the release of their report, the
67: 878:"Senate Affirms Screening Mammography for 40-Year-Olds" 769:
Horner, MJ; Ries, LAG; Krapcho, M; et al. (2009).
231:
to screen asymptomatic women aged 40 to 49 years for
209:
In 2009, the USPSTF updated its advice for screening
16:
US government medical review and recommendation panel
227:
The Task Force made no recommendation about routine
1035:
Agencies of the United States Public Health Service
689:US Preventive Services Task Force (November 2009). 351:"U.S. Preventive Services Task Force: About USPSTF" 262:The USPSTF recommendation, which focuses solely on 871: 869: 867: 519:"An Economic Framework For Preventive Care Advice" 516: 974:Office of Disease Prevention and Health Promotion 851: 768: 481: 1016: 918: 916: 897: 895: 795:"Final Update Summary: Breast Cancer: Screening" 864: 255:, such as Donna Sweet, the former chair of the 976:. Archived from the original on June 15, 2004. 913: 892: 875: 281:political interference in scientific research 266:without regard to cost, formally reduces the 682: 467:: CS1 maint: multiple names: authors list ( 286: 21:United States Preventive Services Task Force 726: 724: 475: 404: 204: 38:Agency for Healthcare Research and Quality 657: 428: 333:"Clinical Guidelines and Recommendations" 178: 771:SEER Cancer Statistics Review, 1975-2006 750:"Stat Fact Sheets: Cancer of the breast" 721: 707:10.7326/0003-4819-151-10-200911170-00008 616:"USPSTF A and B Recommendations by Date" 510: 1025:Federal government of the United States 924:"Prostate Cancer: Screening: Screening" 847: 845: 563: 496:10.7326/0003-4819-147-2-200707170-00171 439:10.7326/0003-4819-147-2-200707170-00170 411:Guirguis-Blake J, Calonge N, Miller T, 367: 1017: 852:Stubbs, Joseph W. (24 November 2009). 736:Agency for Healthcare Research Quality 361: 355:Agency for Healthcare Research Quality 337:Agency for Healthcare Research Quality 970:"U.S. Preventive Services Task Force" 313:Guide to Clinical Preventive Services 68:No weight given to cost-effectiveness 842: 811: 368:Selyukh, Alina (December 18, 2011). 247:, the chief medical officer for the 76: 824: 640:Wong, John B.; Wong, J. B. (2021). 13: 1045:Health policy in the United States 1040:United States national commissions 14: 1056: 998: 907:US Preventive Services Task Force 876:Walker, Emily (3 December 2009). 799:US Preventive Services Task Force 642:"Screening for Colorectal Cancer" 620:US Preventive Services Task Force 602:US Preventive Services Task Force 557: 392:US Preventive Services Task Force 564:Carroll, Aaron E. (2014-12-15). 268:grade given for evidence quality 198:dual-energy X-ray absorptiometry 196:Osteoporosis screening via bone 962: 941: 805: 787: 762: 742: 632: 608: 858:American College of Physicians 836:American College of Physicians 590: 380: 343: 325: 257:American College of Physicians 1: 318: 7: 928:US Preventive Services Task 10: 1061: 305: 240:related to breast cancer. 59: 986:: CS1 maint: unfit URL ( 781:National Cancer Institute 535:10.1377/hlthaff.2013.0873 293:prostate-specific antigen 287:Prostate cancer screening 237:World Health Organization 43: 29:evidence of effectiveness 949:"History Infographic EN" 779:(Report). Bethesda, MD: 388:"Methods and Processes" 376:– via Yahoo News. 253:evidence-based medicine 249:American Cancer Society 205:Breast cancer screening 200:(DEXA) in women over 65 659:10.1001/jama.2021.6238 264:clinical effectiveness 179:Recommended prevention 146:Insufficient evidence 73:small the benefit is. 701:(10): 716–26, W–236. 956:canadiantaskforce.ca 812:Dellorto, Danielle. 299:a C recommendation. 135:Recommended against 598:"Grade Definitions" 838:. 2 December 2009. 570:The New York Times 124:No recommendation 50:medical screenings 652:(19): 1965–1977. 529:(11): 2034–2040. 153: 152: 77:Grade definitions 1052: 992: 991: 985: 977: 966: 960: 959: 953: 945: 939: 938: 936: 934: 920: 911: 910: 899: 890: 889: 887: 885: 873: 862: 861: 849: 840: 839: 828: 822: 821: 809: 803: 802: 791: 785: 784: 766: 760: 759: 746: 740: 739: 728: 719: 718: 695:Ann. Intern. Med 686: 680: 679: 661: 636: 630: 629: 627: 626: 612: 606: 605: 594: 588: 587: 585: 584: 561: 555: 554: 514: 508: 507: 484:Ann. Intern. Med 479: 473: 472: 466: 458: 432: 417:Ann. Intern. Med 408: 402: 401: 399: 398: 384: 378: 377: 365: 359: 358: 357:. November 2014. 347: 341: 340: 329: 85: 84: 34:health economics 1060: 1059: 1055: 1054: 1053: 1051: 1050: 1049: 1015: 1014: 1001: 996: 995: 979: 978: 968: 967: 963: 951: 947: 946: 942: 932: 930: 922: 921: 914: 909:. October 2022. 901: 900: 893: 883: 881: 874: 865: 850: 843: 830: 829: 825: 810: 806: 793: 792: 788: 767: 763: 748: 747: 743: 730: 729: 722: 687: 683: 637: 633: 624: 622: 614: 613: 609: 596: 595: 591: 582: 580: 562: 558: 515: 511: 480: 476: 460: 459: 430:10.1.1.670.8563 409: 405: 396: 394: 386: 385: 381: 366: 362: 349: 348: 344: 331: 330: 326: 321: 308: 289: 207: 181: 79: 70: 62: 46: 17: 12: 11: 5: 1058: 1048: 1047: 1042: 1037: 1032: 1027: 1013: 1012: 1010:USPSTF website 1007: 1000: 999:External links 997: 994: 993: 961: 940: 912: 891: 863: 841: 823: 804: 786: 761: 741: 720: 681: 631: 607: 589: 556: 523:Health Affairs 509: 474: 403: 379: 360: 342: 323: 322: 320: 317: 307: 304: 288: 285: 206: 203: 202: 201: 194: 191: 188: 180: 177: 176: 175: 169: 163: 151: 150: 147: 144: 140: 139: 136: 133: 129: 128: 125: 122: 118: 117: 114: 111: 107: 106: 103: 100: 96: 95: 92: 89: 78: 75: 69: 66: 61: 58: 45: 42: 15: 9: 6: 4: 3: 2: 1057: 1046: 1043: 1041: 1038: 1036: 1033: 1031: 1028: 1026: 1023: 1022: 1020: 1011: 1008: 1006: 1003: 1002: 989: 983: 975: 971: 965: 957: 950: 944: 929: 925: 919: 917: 908: 904: 898: 896: 879: 872: 870: 868: 859: 855: 848: 846: 837: 833: 827: 819: 815: 808: 800: 796: 790: 782: 778: 777: 772: 765: 757: 756: 751: 745: 737: 733: 727: 725: 716: 712: 708: 704: 700: 696: 692: 685: 677: 673: 669: 665: 660: 655: 651: 647: 643: 635: 621: 617: 611: 603: 599: 593: 579: 575: 571: 567: 560: 552: 548: 544: 540: 536: 532: 528: 524: 520: 513: 505: 501: 497: 493: 489: 485: 478: 470: 464: 456: 452: 448: 444: 440: 436: 431: 426: 423:(2): 117–22. 422: 418: 414: 407: 393: 389: 383: 375: 371: 364: 356: 352: 346: 338: 334: 328: 324: 316: 314: 303: 300: 298: 297:PCa screening 294: 284: 282: 277: 272: 269: 265: 260: 258: 254: 250: 246: 241: 238: 234: 233:breast cancer 230: 225: 222: 218: 216: 215:breast cancer 212: 199: 195: 192: 189: 186: 185: 184: 173: 170: 167: 164: 161: 158: 157: 156: 148: 145: 142: 141: 137: 134: 131: 130: 126: 123: 120: 119: 115: 112: 109: 108: 104: 101: 98: 97: 93: 90: 87: 86: 83: 74: 65: 57: 55: 51: 41: 39: 35: 30: 26: 22: 973: 964: 955: 943: 931:. Retrieved 927: 906: 882:. Retrieved 857: 835: 826: 817: 807: 798: 789: 774: 764: 753: 744: 735: 698: 694: 684: 649: 645: 634: 623:. Retrieved 619: 610: 601: 592: 581:. Retrieved 569: 559: 526: 522: 512: 490:(2): 123–7. 487: 483: 477: 463:cite journal 420: 416: 406: 395:. Retrieved 391: 382: 373: 363: 354: 345: 336: 327: 312: 309: 301: 290: 273: 261: 245:Otis Brawley 242: 226: 223: 219: 208: 182: 171: 165: 159: 154: 143:I statement 113:Recommended 102:Recommended 80: 71: 63: 47: 24: 20: 18: 1030:Task forces 276:U.S. Senate 229:mammography 1019:Categories 933:10 October 884:3 December 880:. ABC News 625:2015-10-21 583:2015-10-22 397:2015-10-22 319:References 211:mammograms 54:counseling 676:234769050 578:0362-4331 543:0278-2715 425:CiteSeerX 166:Moderate: 982:cite web 715:19920272 668:34003218 551:25368000 504:17576997 455:19346342 447:17576998 132:Grade D 121:Grade C 110:Grade B 99:Grade A 94:Meaning 958:. 2020. 738:. 2002. 374:Reuters 306:History 91:Result 60:Methods 713:  674:  666:  576:  549:  541:  502:  453:  445:  427:  88:Grade 44:Intent 25:USPSTF 952:(PDF) 672:S2CID 451:S2CID 413:Siu A 988:link 935:2022 886:2009 776:SEER 755:SEER 711:PMID 664:PMID 646:JAMA 574:ISSN 547:PMID 539:ISSN 500:PMID 469:link 443:PMID 172:Low: 160:High 19:The 818:CNN 703:doi 699:151 654:doi 650:325 531:doi 492:doi 488:147 435:doi 421:147 1021:: 984:}} 980:{{ 972:. 954:. 926:. 915:^ 905:. 894:^ 866:^ 856:. 844:^ 834:. 816:. 797:. 773:. 752:. 734:. 723:^ 709:. 697:. 693:. 670:. 662:. 648:. 644:. 618:. 600:. 572:. 568:. 545:. 537:. 527:33 525:. 521:. 498:. 486:. 465:}} 461:{{ 449:. 441:. 433:. 419:. 390:. 372:. 353:. 335:. 283:. 52:, 40:. 990:) 937:. 888:. 860:. 820:. 801:. 783:. 758:. 717:. 705:: 678:. 656:: 628:. 604:. 586:. 553:. 533:: 506:. 494:: 471:) 457:. 437:: 400:. 339:. 23:(

Index

evidence of effectiveness
health economics
Agency for Healthcare Research and Quality
medical screenings
counseling
dual-energy X-ray absorptiometry
mammograms
breast cancer
mammography
breast cancer
World Health Organization
Otis Brawley
American Cancer Society
evidence-based medicine
American College of Physicians
clinical effectiveness
grade given for evidence quality
U.S. Senate
political interference in scientific research
prostate-specific antigen
PCa screening
"Clinical Guidelines and Recommendations"
"U.S. Preventive Services Task Force: About USPSTF"
"Factbox: How the U.S. Preventive Services Task Force works"
"Methods and Processes"
Siu A
CiteSeerX
10.1.1.670.8563
doi
10.7326/0003-4819-147-2-200707170-00170

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.